Form D · Pharmaceuticals
CNS THERAPEUTICS INC
St. Paul, MN · CIK 0001439036
Offering snapshot reported Apr 28, 2011 · SEC filing
- Reported sold
- $3.05M Offering amount: $3.05M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2010 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$3,000,000 → $3,050,000
- Reported investors6 → 7
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2011 | Amendment | $3,050,000 | $50,000vs Jan 4, 2011 | 7 | SEC filing |
| Jan 4, 2011 | Initial | $3,000,000 | No comparison | 6 | SEC filing |
| Aug 20, 2009 | Initial | $7,000,000 | No comparison | 7 | SEC filing |
| Jun 30, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-152901
Source: Form D, filed Apr 28, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Bronson | Executive |
| John Foster | Director, Executive, Promoter |
| Nina Kjellson | Director |
| Andrew La Frence | Executive, Promoter |
| Peter Mc Nerney | Director |
| Richard Penn | Executive, Promoter |
| Howard Rosen | Director |
| Pratik Shah | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
332 Minnesota Street Suite W1750
St. Paul, MN, 55101
St. Paul, MN, 55101